KTM
ABBV icon

Keeler Thomas Management’s AbbVie ABBV Stock Holding History

Keeler Thomas Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,097
Closed -$340K – 67
2022
Q1 		$340K Sell
2,097
-586
-22% -$85.1K 0.16% 58
2021
Q4 		$363K Sell
2,683
-83
-3% -$9.8K 0.16% 62
2021
Q3 		$298K Hold
2,766
– – 0.14% 65
2021
Q2 		$311K Hold
2,766
– – 0.15% 65
2021
Q1 		$299K Sell
2,766
-2,748
-50% -$294K 0.16% 62
2020
Q4 		$590K Sell
5,514
-27,748
-83% -$2.67M 0.33% 56
2020
Q3 		$2.91M Buy
33,262
+6,351
+24% +$598K 1.83% 27
2020
Q2 		$2.64M Buy
26,911
+10,961
+69% +$965K 1.91% 21
2020
Q1 		$1.22M Sell
15,950
-12,777
-44% -$1.09M 1.42% 26
2019
Q4 		$2.54M Sell
28,727
-415
-1% -$34.5K 1.81% 22
2019
Q3 		$2.21M Buy
29,142
+4,704
+19% +$323K 1.7% 25
2019
Q2 		$1.78M Buy
24,438
+4,050
+20% +$318K 1.42% 28
2019
Q1 		$1.64M Buy
20,388
+7,300
+56% +$597K 1.38% 28
2018
Q4 		$1.21M Buy
13,088
+2,883
+28% +$254K 1.39% 23
2018
Q3 		$965K Buy
10,205
+4,717
+86% +$447K 0.8% 36
2018
Q2 		$508K Buy
5,488
+2,800
+104% +$273K 0.47% 46
2018
Q1 		$254K Sell
2,688
-3,800
-59% -$417K 0.25% 53
2017
Q4 		$627K Buy
+6,488
New +$611K 0.58% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Keeler Thomas Management's ABBV Position: Q2 2022 in Review

Keeler Thomas Management sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,097 shares — an estimated $340K sold.

Keeler Thomas Management first reported a position in ABBV in Q4 2017 and held it in 18 quarters. The position peaked at $2.91M in Q3 2020. 3,006 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Keeler Thomas Management reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Keeler Thomas Management sold 2,097 AbbVie shares in Q2 2022, an estimated $340K.
  • Keeler Thomas Management first reported a position in AbbVie in Q4 2017 and held it in 18 quarters.
  • Keeler Thomas Management's AbbVie position peaked at $2.91M in Q3 2020.
  • 3,006 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Keeler Thomas Management's 13F filing for Q2 2022, filed 29 Jul 2022.